Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from biotechnology

The long – and strange – history of testing menstrual blood for health conditions

There’s good news for anyone who menstruates and doesn’t like the needles involved in blood testing. In January 2024, the biotechnology research company Qvin won FDA approval for their Q-Pad product – a menstrual pad with a removable strip to collect blood samples for clinical tests. It offers a needle-free…

The Conversation

Chart of the Day: Dyne Therapeutics - Deeply Discounted

The Chart of the Day belongs to the biotechnology company Dyne Therapeutics (DYN) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart...

Barchart

Why places like Birmingham, Alabama are key to securing U.S. biotech dominance as China tries to close the gap

If America has any hope of maintaining its leadership in biotechnology, we must invest in places like Alabama.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Dr. Ashkan Afshin Is Steadily Unlocking The Potential Of Biotechnology To Revolutionize Healthcare

Dr. Afshin's early career was marked by his work at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, an institute funded by the Gates Foundation.

International Business Times

India, US to initiate new cooperation in quantum tech, biomanufacturing; announce collaboration on telecommunication

India and the US have agreed to initiate new cooperation in the field of quantum science and technology and also develop a joint strategic framework for building biopharmaceutical supply chain optimization. Read further on Dynamite News:

Dynamite News

How Is Regeneron Pharmaceuticals' Stock Performance Compared to Other Biotechnology Stocks?

Regeneron Pharmaceuticals has outperformed the broader market over the past year, and Wall Street analysts are optimistic about the stock’s outlook.

Barchart

3 Cathie Wood Biotech Stocks That Analysts Expect to Double

This article delves into three biotech stocks held in Cathie Wood's ARKK ETF that analysts expect to double in value. Investors looking to add exposure to promising biotech opportunities, with a preference for Wood's disruptive approach to investing, may find these stocks particularly compelling.

Barchart

Read news from The Economist, FT, and more,
with one subscription

3 Biotech Stocks Under $20 Worth Watching in June

The biotech industry’s long-term expansion is fueled by increasing medical needs globally, favorable government support, and technological advances. Given the industry’s rosy outlook, quality biotech stocks Equillium (EQ), SIGA Technologies (SIGA), and Shionogi & Co. (SGIOY) trading under $20 could be worth watching in June. Keep reading….

StockNews.com

3 Value Biotech Stocks With Breakout Potential in 2024

Given growing healthcare spending, supportive government policies, and technological innovation, the biotechnology industry is poised for solid long-term growth. Thus, investors could consider buying quality biotech stocks Harmony Biosciences (HRMY), Esperion Therapeutics (ESPR), and Entrada Therapeutics (TRDA), which are trading at a discount. Read on….

StockNews.com

3 A-Rated Biotech Stocks for Long-Term Investors

The future of the biotech industry appears bright, driven by extensive usage across healthcare and agriculture alongside rapid advancements in technology. Thus, top biotech stocks Entrada Therapeutics (TRDA), Exelixis (EXEL), and Gilead Sciences (GILD) could be solid buys for long-term investors. These stocks are rated A (Strong Buy) in our…

StockNews.com

3 Biotech Stocks to Consider Buying Right Away

The biotechnology industry is thriving, fueled by solid government support, rising healthcare spending worldwide, gene editing breakthroughs, and rapid AI adoption. Hence, fundamentally solid biotech stocks Shionogi (SGIOY), United Therapeutics (UTHR), and SIGA Technologies (SIGA) could be ideal buys for potential gains. Keep reading….

StockNews.com

3 Biotech Stocks Heating up for May

The biotech industry is expected to grow rapidly due to rising medical needs globally, favorable government initiatives, and rapid AI adoption. Amid this backdrop, quality biotech stocks Royalty Pharma (RPRX), Anika Therapeutics (ANIK), and Innoviva (INVA) could be ideal investments this month. Read more….

StockNews.com

National Institute of Animal Biotechnology dedicates solar grid of 900 kWp

NIAB Hyderabad inaugurates 900 kWp solar grid, saving ₹1 crore in energy costs and reducing CO2 emissions.

The Hindu

Greenpeace Crusade Will Blind and Kill Children

One hundred Nobel laureates agree: The campaign against biotech-enhanced golden rice is a "crime against humanity."

Reason

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Biotech Stocks to Invest In Right Now for Long-Term Gains

With the rapidly growing demand for personalized medicine, innovative solutions, and recent developments like AI in drug discovery, the biotech industry's prospects appear robust. Thus, quality biotech stocks Vertex Pharmaceuticals (VRTX), SIGA Technologies (SIGA), and Gilead Sciences (GILD) could be ideal candidates to buy now. Read more….

StockNews.com

3 Biotech Gems Poised for April Breakthroughs

The biotechnology industry is expected to grow rapidly due to rising demand for personalized medicines, increased R&D spending, and the adoption of AI in the biopharma market. Hence, quality biotech stocks Incyte (INCY), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL) could be poised for breakthroughs this month. Read more….

Wallpaper

Gezeiten’s biotech skincare works in harmony with your circadian rhythm

Gezeiten uses biotechnology to create skincare products that harness the body’s natural rhythms

Reason

Drug Company's Libel Lawsuit Against Scientists Dismissed

From yesterday's decision by Judge Gregory Woods (S.D.N.Y.) in Cassava Sciences, Inc. v. Bredt: Cassava Sciences, Inc. ("Cassava") is a biotechnology company that is conducting clinical trials for an Alzheimer's drug called simufilam. Following the second phase of the simufilam clinical trials, multiple short sellers, most of them scientists, published…

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

SPMVV receives ₹47.9 lakh grant from the government’s Department of Biotechnology

SPMVV's WBIF receives grant for biotech facility maintenance, training, and innovation, aiding students, faculty, researchers, and entrepreneurs.

Top News

Exploring The Top 10 Innovations In Biotechnology And Agriculture

Discover the top 10 biotechnology breakthroughs in agriculture, from GMOs to precision farming.

StockNews.com

3 Pharma Gems Poised for Breakthroughs

The pharmaceutical industry is rapidly expanding, fueled by continued R&D efforts leading to the discovery of new drugs and therapies, biotechnology innovations, and growing medical needs. Thus, let’s take a look at pharma gems Pacira BioSciences (PCRX), Calliditas Therapeutics (CALT), and Astellas Pharma (ALPMY) poised for breakthroughs. Read more….

StockNews.com

Top Biotech 3 Stocks With Accelerating Profits

The biotechnology industry is booming thanks to growing demand for innovative healthcare solutions, favorable government initiatives, and several scientific breakthroughs. Thus, quality biotech stocks Genmab (GMAB), Halozyme Therapeutics (HALO), and Vertex Pharmaceuticals (VRTX) could be ideal buys for substantial profits. Read more….

StockNews.com

Bank on the Future Returns With These 3 Biotech Stocks

With advances in gene therapy and personalized medicine, growing applications in agriculture and industrial processes, government support, and convergence of technologies, the biotechnology industry holds solid growth potential. Thus, biotech stocks United Therapeutics (UTHR), Puma Biotechnology (PBYI), and Genmab (GMAB) could be ideal investments for future returns. Read more….

StockNews.com

3 Biotech Stocks to Buy for Profits Beyond 2024

The biotech industry is expected to deliver steady returns amid rising medical needs and increased research and development investment. Therefore, fundamentally strong biotech stocks Illumina (ILMN), Innoviva (INVA) and Puma Biotechnology (PBYI) might be ideal additions to your portfolio. Read on.

International Business Times

20 Highest-Grossing Biotech Stocks: Giants Driving Innovation and Growth

Biotech stocks offers the potential for significant returns driven by breakthrough discoveries and advancements in healthcare, agriculture, and other industries.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.